Cargando…

Risk Factors for Readmission in Patients with Outpatient Parenteral Antimicrobial Therapy

BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is a practical and effective way of delivering antimicrobial therapy, but may be associated with significant risk for hospital readmission. This study aimed to elucidate risk factors related to 30-day readmissions in patients who were di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Victoria, Lerner, Polina, Ruhe, Jorg, Fedorenko, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632050/ http://dx.doi.org/10.1093/ofid/ofx163.793

Ejemplares similares

Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study
por: Huang, Victoria, et al.
Publicado: (2018)

622. Risk Factors for 30-Day Unplanned Readmissions in Patients Discharged with Outpatient Parenteral Antimicrobial Therapy
por: Shah, Megan, et al.
Publicado: (2020)

1939. Socioeconomic Predictors of Hospital Readmission in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients
por: Hamad, Yasir, et al.
Publicado: (2018)

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
por: Bradley, Abby C., et al.
Publicado: (2023)

1944. Patients With Prosthetic Joint Infections Receiving Outpatient Parenteral Antimicrobial Therapy: Characteristics and Readmission Rates
por: Gore, Sara, et al.
Publicado: (2018)

1298 Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Means, Laura, et al.
Publicado: (2014)

332. Factors Associated with Readmission in Patients with End-Stage Renal Disease on Hemodialysis Discharged on Outpatient Parenteral Antimicrobial Therapy
por: Ismail, Ghaleb, et al.
Publicado: (2023)

600. Decreased Hospital Readmission After Programmatic Strengthening of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Agnihotri, Gaurav, et al.
Publicado: (2020)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

351. Factors Predicting Readmission within 90 days in Patients Receiving Outpatient Parenteral Antibiotic Therapy
por: Smola, Kyle, et al.
Publicado: (2023)

Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study
por: Douiyeb, Sabrine, et al.
Publicado: (2022)

537. Outpatient Parenteral Antimicrobial Therapy Readmissions from Post-Acute Care Facilities due to Coronavirus Disease 2019
por: Burnett, Yvonne, et al.
Publicado: (2020)

Outpatient Parenteral Antibiotic Therapy (OPAT) Serial Readmissions and High Utilizers: Drilling Down on Readmission Following Discharge on Intravenous Antibiotics
por: Andrews, Mary-Margaret, et al.
Publicado: (2017)

1933. Economic Evaluation of Outpatient Parenteral Antimicrobial Therapy in Children
por: Krah, Nathan, et al.
Publicado: (2018)

1855. Antimicrobial Stewardship (AMS) and the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting
por: Friedman, N Deborah
Publicado: (2018)

Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study
por: Douiyeb, Sabrine, et al.
Publicado: (2022)

Characterization of Readmissions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program Over a 2-Year Period at UNC Medical Center
por: Nwankwo, Onyeka, et al.
Publicado: (2017)

2081. Low 30-Day Hospital Readmission Rates in Medicare Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers
por: Luu, Quyen, et al.
Publicado: (2019)

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population
por: Van Anglen, Lucinda J, et al.
Publicado: (2017)

330. Outpatient Parenteral Antimicrobial Therapy in People who Inject Drugs
por: Hawes, Armani, et al.
Publicado: (2023)

353. Outpatient parenteral antimicrobial therapy (OPAT) in managing vertebral osteomyelitis
por: Villacorta Cari, Evelyn, et al.
Publicado: (2023)

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Nathan, Ramesh V, et al.
Publicado: (2017)

Follow-up Appointment Adherence of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients
por: Lall, Ambika, et al.
Publicado: (2017)

Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program
por: Agnihotri, Gaurav, et al.
Publicado: (2023)

Emergency Department Utilization During Self-Administered Outpatient Parenteral Antimicrobial Therapy
por: Ganguly, Anisha, et al.
Publicado: (2017)

777. Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Burnett, Yvonne, et al.
Publicado: (2019)

325. Outcomes of Outpatient Parenteral Antimicrobial Therapy in the Solid Organ Transplant Population
por: Dillon, William P, et al.
Publicado: (2023)

1942. Expansion of Outpatient Parenteral Therapy Program with Addition of Advanced Practice Providers Can Lead to Reduced Readmission Rates
por: Wingfield, Joshua, et al.
Publicado: (2018)

688. Risk of Clostridioides difficile Infection and Antibiotic Associated Diarrhea in Patients Receiving Outpatient Parenteral Antimicrobial Therapy
por: Jaramillo, Mario, et al.
Publicado: (2023)

623. Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) in Uninsured Patients
por: Hamad, Yasir, et al.
Publicado: (2020)

Emergency Department Visits During Outpatient Parenteral Antimicrobial Therapy: A Cohort Study
por: Kim, So Lim, et al.
Publicado: (2017)

1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
por: Rizvi, Hira, et al.
Publicado: (2018)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

763. 30 Day Readmission Outcomes in Patients Over 80 Years of Age Enrolled in an Outpatient Parenteral Antibiotic Therapy (OPAT) Program
por: Sheridan, Kathleen R, et al.
Publicado: (2019)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications
por: Kaul, Christina, et al.
Publicado: (2022)

335. Factors Associated with Loss to Follow-Up in Outpatient Parenteral Antimicrobial Therapy: A Retrospective Cohort Study
por: Kaul, Christina M, et al.
Publicado: (2023)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

608. Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
por: Kirkpatrick, Emily R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_es998s35q3nr5pgd2nie83t0u1